Dr. Mazen Mislmani, MD

  • Kalamazoo, MI
  • Radiation oncologist
NPI1538489554PAC ID2668786567
Medicare services, 2024
2,823
Medicare patients, 2024
137
Part D claims, 2024
94
MIPS score, 2024
87
Hospital affiliations
2
Practice address
601 John Street, Kalamazoo, MI 49007
Practice phone
Call (269) 341-6000
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Bronson Methodist Hospital

Hospital · Kalamazoo, Michigan

See all 4 affiliations

Find Dr. Mislmani's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Mazen Mislmani is a radiation oncologist in Kalamazoo, Michigan

Dr. Mislmani practices at Bronson Methodist Hospital in Kalamazoo, Michigan, part of Bronson Healthcare Group.

Dr. Mislmani's NPI, 1538489554, was assigned on June 2, 2010. Dr. Mislmani graduated from Wayne State University School of Medicine in 2010. Dr. Mislmani holds Michigan license 4301096631.

NPI and contact details
Medicare PAC ID
2668786567
NPI enumeration date
June 2, 2010
NPI status
Active
Accepts Medicare assignment
Yes
Practice phone
(269) 341-6000
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
42
Medical school graduation
2010

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Mazen Mislmani practices at Bronson Methodist Hospital in Kalamazoo, Michigan

Dr. Mislmani's primary practice is Bronson Methodist Hospital, at 601 John Street, Kalamazoo, MI 49007 in Kalamazoo County. The practice phone is (269) 341-6000.

Source: Dmand AI Affiliation Data

Dr. Mazen Mislmani is affiliated with 3 sites of care and 1 medical group

Dr. Mislmani's primary practice is Bronson Methodist Hospital in Kalamazoo, Michigan, part of Bronson Healthcare Group. Dr. Mislmani is also affiliated with Bronson LakeView Hospital. The medical group on file is West Michigan Cancer Center. Dmand AI also links Dr. Mislmani to 1 more group practice or clinic, named with a free account.

See all 4 affiliations for Dr. Mislmani

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Mazen Mislmani's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mislmani practices, 3 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Bronson Methodist HospitalAvailable with a free account
+2 more affiliated sitesAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Mislmani practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across Bronson Healthcare Group and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Mazen Mislmani is one of 200 radiation oncologists in Michigan

Radiation oncology is Dr. Mislmani's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Mislmani is licensed in Michigan.

Specialties and state licenses

  • Radiation oncology, MichiganPrimaryLicense 4301096631 · taxonomy 2085R0001X

Radiation oncologists near Dr. Mislmani

Counts of radiation oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Mazen Mislmani billed Medicare for 2,823 services in 2024

CMS data shows 2,823 Medicare services from Dr. Mislmani across 18 procedure codes in 2024, for 137 Medicare patients. Medicare paid $467,682 for them. Every service was in an office.

Medicare services, 20242,823
Medicare patients137
Paid by Medicare$467,682
Procedure codes18

Dr. Mislmani's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Imaging
2023: 1,7452024: 1,6933%
Other services
2023: 1,0152024: 1,0796%
Office and hospital visits
2023: 492024: 514%

Dr. Mislmani compared with the Michigan median for radiation oncologists, 2024

  • Dr. Mislmani
  • Michigan median
Medicare services
2,823vs 1,1482.5 times
Medicare patients
137vs 133Close to median
Part D claims
54vs 3842% above

Medians across 184 radiation oncologists in Michigan with Dmand AI profiles that report each measure.

Dr. Mislmani's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Mislmani

Need commercial claims for Dr. Mislmani?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Mislmani and other radiation oncologists in Michigan.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Mazen Mislmani treated 137 Medicare patients in 2024, average age 74

CMS counts 137 Medicare patients who saw Dr. Mislmani in 2024. The largest group is 65 to 74, with 76 patients. 75% of them have cancer, and 70% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mislmani's median patient age at 71, with 50% women.

Medicare patients, 2024137
Average age74
Average risk score1.52
Also on Medicaid13%

Dr. Mislmani's Medicare patients by age, 2024

CMS leaves out age groups with fewer than 11 patients.

Dr. Mislmani's Medicare patients by sex, 2024

  • Women4835%
  • Men8965%

Chronic conditions among Dr. Mislmani's Medicare patients, 2024

  1. Cancer75%
  2. High cholesterol70%
  3. High blood pressure61%
  4. Arthritis38%
  5. Diabetes31%
  6. Ischemic heart disease31%
  7. COPD25%
  8. Mood disorders23%

Share of Medicare patients with each condition. A patient can have several.

Dr. Mislmani's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 71

Patient panel by sex, all payers

  • Women50%
  • Men49%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Mazen Mislmani wrote 94 Medicare Part D claims in 2024

In 2024, Dr. Mislmani wrote 94 Medicare Part D claims for 51 patients. 97% of them were for generic drugs. CMS names the drug for 54 of them, across 1 drug with 11 or more claims each, at $1,409 in total drug cost. In 2023, CMS named 65 claims across 1 drug.

Part D claims, 202494
Drugs named by CMS1
Total drug cost$1,409
Part D patients51

Dr. Mislmani's Part D claims by kind of drug, 2024

  • Generic91 claims97%
  • Brand-name and other3 claims3%

Dr. Mislmani's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Mislmani's Part D claims, 2024

  • Antibiotics12%11 of 94 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 652024: 5417%

Drugs named by CMS: 1 in 2024, 1 in 2023.

See all prescribing by Dr. Mislmani

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Mazen Mislmani scored 87 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Mislmani for performance year 2024, reported as part of a group. Dr. Mislmani accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes

Dr. Mislmani's MIPS scores, performance year 2024

  • 87of 100Final score
  • 100of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities
  • 57of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find radiation oncologists like Dr. Mislmani by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Mazen Mislmani received $406 in industry payments from 2016 to 2024

CMS Open Payments shows 6 general payments to Dr. Mislmani from 5 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Boston Scientific Corporation paid the most, $137.

General payments to Dr. Mislmani by program year, 2016 to 2024

Companies that paid Dr. Mislmani the most, 2016 to 2024

Share is of all general payments to this clinician.

See all payments to Dr. Mislmani

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Mazen Mislmani graduated from Wayne State University School of Medicine

Dr. Mislmani graduated from Wayne State University School of Medicine in 2010.

  1. Medical schoolWayne State University School of Medicine

Source: Dmand AI Professional Profile Data

Sources for Dr. Mazen Mislmani's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Mazen Mislmani

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Mazen Mislmani's NPI number?

Dr. Mazen Mislmani's NPI number is 1538489554. It was assigned on June 2, 2010, and it is active in the NPI Registry.

What kind of doctor is Dr. Mazen Mislmani?

Dr. Mazen Mislmani is a radiation oncologist in Kalamazoo, Michigan. The primary specialty in the NPI Registry is Radiation Oncology Physician (taxonomy code 2085R0001X).

Where does Dr. Mazen Mislmani practice?

Dr. Mislmani practices at 601 John Street, Kalamazoo, MI 49007. Dr. Mislmani's primary practice is Bronson Methodist Hospital in Kalamazoo, Michigan, part of Bronson Healthcare Group. Dmand AI also links Dr. Mislmani to 1 group practice or clinic.

What is Dr. Mazen Mislmani's office phone number?

The practice phone on file for Dr. Mislmani is (269) 341-6000.

What is Dr. Mazen Mislmani's medical license number?

Dr. Mislmani holds Michigan license 4301096631.

Which hospitals is Dr. Mazen Mislmani affiliated with?

Dr. Mislmani practices at Bronson Methodist Hospital in Kalamazoo, Michigan. Dr. Mislmani is also affiliated with Bronson LakeView Hospital.

What medical group is Dr. Mazen Mislmani part of?

Dr. Mislmani is linked to West Michigan Cancer Center.

Does Dr. Mazen Mislmani accept Medicare?

Yes. CMS data shows Dr. Mislmani billed Medicare for 2,823 services in 2024, and Dr. Mislmani accepts Medicare assignment.

What is Dr. Mazen Mislmani's MIPS score?

Dr. Mislmani's MIPS final score for performance year 2024 is 87 out of 100, reported as part of a group.

How many Medicare patients does Dr. Mazen Mislmani see?

CMS counts 137 Medicare patients who saw Dr. Mislmani in 2024, with an average age of 74.

Show 5 more questionsShow fewer questions

What services does Dr. Mazen Mislmani bill to Medicare?

In 2024, Dr. Mislmani's most billed Medicare services were radiation oncology (77014), medicare service (G6015) and radiation oncology (77427).

Where did Dr. Mazen Mislmani go to medical school?

Dr. Mislmani graduated from Wayne State University School of Medicine in 2010.

What drugs does Dr. Mazen Mislmani prescribe most?

In 2024 Medicare Part D data, Dr. Mislmani's most prescribed drugs by claims were Tamsulosin HCl.

Has Dr. Mazen Mislmani received payments from drug or device companies?

CMS Open Payments shows $406 in general payments to Dr. Mislmani from 5 companies from 2016 to 2024. The largest total came from Boston Scientific Corporation.

How long has Dr. Mazen Mislmani been practicing?

Dr. Mislmani graduated from medical school in 2010, 16 years ago.

Selling to radiation oncology practices?

See radiation oncologists in Michigan by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)